Related Experiment Video
Updated: Sep 14, 2025

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.9K
Development of a clinical decision support system for breast cancer detection using ensemble deep learning
Jasjeet Kaur Sandhu1, Chetna Sharma1, Amandeep Kaur1
1Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.
Scientific Reports
|July 18, 2025
Summary
A novel Deep Learning (DL) Ensemble Clinical Decision Support System (EDL-CDSS) enhances breast cancer diagnosis. This advanced system achieves 96.14% accuracy, improving early detection and patient outcomes.
Area of Science:
- Medical Imaging Analysis
- Artificial Intelligence in Healthcare
- Oncology Diagnostics
Background:
- Breast cancer poses a significant global health challenge, necessitating improved diagnostic technologies for early detection and better patient outcomes.
- Current diagnostic methods face limitations in precision and speed, highlighting the need for advanced computational approaches.
Purpose of the Study:
- To develop and evaluate a unique Deep Learning (DL) Ensemble Clinical Decision Support System (EDL-CDSS) for precise and rapid breast cancer diagnosis.
- To improve the accuracy and efficiency of breast cancer detection by combining multiple DL models.
Main Methods:
- The study proposes an EDL-CDSS integrating various DL models, including Kelm Extreme Learning Machine (KELM) and Deep Belief Network (DBN).
- This ensemble approach leverages the strengths of individual DL architectures to extract complex patterns from medical imaging data.
- The system's performance was rigorously tested on diverse datasets, comparing it against individual DL models and traditional diagnostic techniques.
Main Results:
- The EDL-CDSS demonstrated superior performance in diagnosing breast cancer compared to individual DL models and conventional methods.
- Key performance metrics evaluated included precision, sensitivity, specificity, F1-score, and overall accuracy.
- The system achieved a remarkable overall accuracy of 96.14%, significantly outperforming prior advanced methodologies.
Conclusions:
- The developed EDL-CDSS offers a promising advancement in breast cancer diagnostic technology.
- The ensemble DL approach effectively enhances diagnostic precision and speed, potentially leading to improved patient outcomes.
- This system shows significant potential for clinical application in early and accurate breast cancer detection.

